VentriPoint Diagnostics Ltd
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provid… Read more
VentriPoint Diagnostics Ltd (VPTDF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.015x
Based on the latest financial reports, VentriPoint Diagnostics Ltd (VPTDF) has a cash flow conversion efficiency ratio of 0.015x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-68.71K) by net assets ($-4.66 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
VentriPoint Diagnostics Ltd - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how VentriPoint Diagnostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
VentriPoint Diagnostics Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of VentriPoint Diagnostics Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PEPTONIC MEDICAL
F:28L
|
N/A |
|
Murray Cod Australia Ltd
AU:MCA
|
-0.066x |
|
Delta Djakarta Tbk
JK:DLTA
|
0.097x |
|
Sutlej Textiles and Industries Limited
NSE:SUTLEJTEX
|
0.129x |
|
Dreamfolks Services Limited
NSE:DREAMFOLKS
|
0.006x |
|
China Changbaishan International Holdings Limited
F:CL70
|
N/A |
|
Skane mollan AB
ST:SKMO
|
0.157x |
|
Bokusgruppen AB
ST:BOKUS
|
0.097x |
Annual Cash Flow Conversion Efficiency for VentriPoint Diagnostics Ltd (2005–2024)
The table below shows the annual cash flow conversion efficiency of VentriPoint Diagnostics Ltd from 2005 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-2.98 Million | $-3.39 Million | 1.136x | +105.66% |
| 2023-12-31 | $189.71K | $-3.80 Million | -20.052x | -2107.17% |
| 2022-12-31 | $4.55 Million | $-4.14 Million | -0.908x | -140.60% |
| 2021-12-31 | $8.33 Million | $-3.15 Million | -0.378x | -180.59% |
| 2020-12-31 | $-2.35 Million | $-1.10 Million | 0.469x | -51.41% |
| 2019-12-31 | $-2.47 Million | $-2.38 Million | 0.964x | -69.22% |
| 2018-12-31 | $-973.26K | $-3.05 Million | 3.133x | +65.95% |
| 2017-12-31 | $-1.63 Million | $-3.07 Million | 1.888x | +93.11% |
| 2016-12-31 | $-2.25 Million | $-2.20 Million | 0.978x | -83.62% |
| 2015-12-31 | $-269.66K | $-1.61 Million | 5.967x | +1033.35% |
| 2014-12-31 | $-2.40 Million | $-1.26 Million | 0.526x | -36.40% |
| 2013-12-31 | $-3.12 Million | $-2.58 Million | 0.828x | -49.84% |
| 2012-12-31 | $-2.65 Million | $-4.37 Million | 1.650x | -3.38% |
| 2011-12-31 | $-2.33 Million | $-3.98 Million | 1.708x | -27.65% |
| 2010-12-31 | $-860.17K | $-2.03 Million | 2.360x | +434.52% |
| 2009-12-31 | $-3.26 Million | $-1.44 Million | 0.442x | -80.32% |
| 2008-12-31 | $-1.87 Million | $-4.20 Million | 2.244x | +682.50% |
| 2007-12-31 | $2.50 Million | $-965.08K | -0.385x | -590.65% |
| 2006-12-31 | $670.44K | $-37.40K | -0.056x | -886.77% |
| 2005-12-31 | $695.36K | $-3.93K | -0.006x | -- |